Baker Bros. Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,455,202
| Closed | -$55.9M | – | 114 |
|
|
2023
Q2 | $55.9M | Hold |
1,455,202
| – | – | 0.32% | 22 |
|
|
2023
Q1 | $33.7M | Sell |
1,455,202
-1,078,900
| -43% | -$25M | 0.18% | 29 |
|
|
2022
Q4 | $66.4M | Hold |
2,534,102
| – | – | 0.4% | 18 |
|
|
2022
Q3 | $49.8M | Hold |
2,534,102
| – | – | 0.33% | 27 |
|
|
2022
Q2 | $44.3M | Buy |
2,534,102
+200,000
| +9% | +$3.5M | 0.25% | 28 |
|
|
2022
Q1 | $38.2M | Hold |
2,334,102
| – | – | 0.22% | 36 |
|
|
2021
Q4 | $38.1M | Buy |
2,334,102
+431,033
| +23% | +$7.03M | 0.19% | 41 |
|
|
2021
Q3 | $24.3M | Buy |
1,903,069
+822,676
| +76% | +$10.5M | 0.11% | 57 |
|
|
2021
Q2 | $15.3M | Buy |
1,080,393
+331,700
| +44% | +$4.68M | 0.07% | 68 |
|
|
2021
Q1 | $11.6M | Hold |
748,693
| – | – | 0.05% | 72 |
|
|
2020
Q4 | $11.9M | Buy |
+748,693
| New | +$11.9M | 0.04% | 69 |
|